When: $162 retest with FCF coverage >1.30x

Then: Re-engage to Hold

SELL with 30-40% trim; trim at $173-$174, exit remainder if closes below $171 on volume, consider rebuilding if breaks above $179 with volume

• Barclays upgrade is a coincident indicator (published after 7.6% rally from $162 to $174), not a leading one
• DCF discount-to-fair-value framing is sensitive: 5.5% cost of debt and 4.0% terminal growth converts 40% discount to 15% premium
• Macro constraints unaltered: Polymarket pricing 1% September cut odds and 10% December cut odds; Core PCE at 3.1-3.3%; 10-year Treasury at 4.7%
• 24x P/E with 5.5x net leverage is mispriced for higher-for-longer regime where rate cuts are 1% probability event
• MACD histogram compressed 76% from 1.33 to 0.32 over sixteen sessions—not a coiled spring but momentum exhaustion
• Three 200 SMA rejections on 8/24, 8/25, and 8/26 with highs at $178.39 and $178.57; needs to close above $175.39 to flip long-term trend
• ATR compression at 4.19 (down from 5.50 during panic low) resolves in both directions; same setup preceded $194-to-$162 drop
• 3.97% dividend yield is a coupon, not a floor—can expand to 5-6% as price falls in rate-driven re-rating
• FCF coverage at 83% with $45 billion debt and $1.36 billion annual interest expense is vulnerable if yields break above 4.9%
• CoreSite 'free optionality' is misleading—$26.79 billion goodwill and intangibles on balance sheet means we paid for it
• ATR compression in early August at 5.27 preceded $194-to-$162 drop in three weeks—same setup now in opposite direction risk
• Conservative view: requires only avoiding permanent capital impairment; aggressive view requires rates falling, valuation gaps closing, and AI-infrastructure narratives materializing simultaneously

→ vs aggressive: Barclays upgrade is post-hoc rationalization—sell-side has documented history of upgrading after easy money made; $162 entry was the thesis, not $174

→ vs aggressive: 40% DCF discount is assumption-dependent; changing terminal growth from 3% to 4% and cost of debt to 5.5% flips it to 15% premium

→ vs aggressive: 'Priced in' argument is dangerous—Polymarket shows 1% probability of rate relief; macro environment can still deteriorate from here

→ vs aggressive: MACD bullish cross is already releasing—76% histogram compression shows momentum exhaustion, not coiled spring

→ vs aggressive: ATR compression doesn't predict direction; same setup existed in August at 5.27 ATR before $32 drop

→ vs aggressive: 3.97% yield is not a hard floor; it can expand to 5-6% as price falls when discount rate rises (see REITs 2022)

→ vs aggressive: CoreSite 'free optionality' ignores $26.79 billion goodwill on balance sheet—we paid for it through equity dilution

→ vs aggressive: $169.50 stop is not too tight—1.5% stop on stock that rejected 200 SMA three times is appropriate

SELL with 15-25% trim at 173-174, stop at 167.73, re-enter above 179.50 on volume; rotate 30-50% of trim proceeds to shorter-duration REITs

• Rating is SELL; trim direction is correct but 30-40% is too aggressive—recommend 15-25% instead
• Entry should be tightened to 173-174 (not 173-175) to capture the 200 SMA supply zone precisely
• Stop should be widened to 167.73 (Bollinger lower band) for 1.5 ATR of room rather than 169.50 at 1.07x ATR
• Dividend at 3.97% yield with 83% FCF coverage is real cash generation, not illusory—contradicts Conservative view
• FCF growth of 108% and operating margin expansion from 30% to 46% are durable improvements underweighted by Conservative
• Net debt reduction of 3.7 billion dollars represents real deleveraging over four years
• AMT 5-year TSR of minus 27.5 percent suggests much pessimism is priced in at 174
• MACD histogram compression from 1.33 to 0.32 over sixteen sessions confirms momentum exhaustion
• 10-year yields at 4.9 percent risk threshold could worsen refinancing calculus if broken
• Polymarket pricing only 1% September cut odds and 10% December cut odds suggests market not pricing relief
• Barclays upgrade is a meaningful signal but likely coincident rather than leading
• Customer escalator at 3 percent below Core PCE of 3.1-3.3 percent is structural real-terms revenue erosion
• CoreSite is not free optionality—it was purchased through 26.79 billion dollars of goodwill and intangibles with dilution
• Defined re-entry framework: add back above 179.50 on volume with stop below 175
• Exit remainder on close below 167.73 on volume, not 171 (50 SMA produces false breaks)
• Rotate 30-50% of trim proceeds to less rate-sensitive REITs (healthcare, industrial) rather than cash

→ vs aggressive: Dismissal of macro headwinds is too glib—Polymarket pricing 1% September/10% December cut odds means market is not pricing relief, and a 10-year yield break above 4.9% makes decade-low valuations a value trap

→ vs aggressive: CoreSite characterization as 'free optionality' is sloppy—26.79 billion dollars of goodwill and intangibles traces to acquisitions, meaning dilution and balance sheet leverage were the price paid

→ vs aggressive: Proposed hedging (6-month puts or covered calls) contradicts own conviction—if truly believing coiled spring resolves to 185-190, should hold full size, not hedge

→ vs conservative: Treatment of dividend as illusory is wrong—a 3.97% yield on 83% FCF coverage with deleveraging and resumed buybacks is real cash generation that improves risk-adjusted returns

→ vs conservative: Stop at 169.50 is not generous—ATR of 4.19 means 4.50 dollar distance is 1.07x ATR, which is tight; 1x ATR would be 169.81, nearly identical to trader's stop

→ vs conservative: Dismissal of structural improvements (108% FCF growth, 46% operating margins, 3.7 billion dollars deleveraging) underweights real business quality improvements from 2022

→ vs conservative: Hard re-entry rule of exit on close below 171 with volume is too rigid—171 is the 50 SMA and would produce false breaks given declining slope; 167.73 is cleaner exit trigger